𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prediction of locoregional extension and metastatic disease in prostate cancer: a review

✍ Scribed by Thomas Reckwitz; Steven R. Potter; Alan W. Partin

Book ID
105745014
Publisher
Springer-Verlag
Year
2000
Tongue
English
Weight
142 KB
Volume
18
Category
Article
ISSN
0724-4983

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Decreased expression of cd44 in metastat
Decreased expression of cd44 in metastatic prostate cancer
✍ Marinus A. Noordzij; Gert Jan van Steenbrugge; Fritz H. SchrΓΆder; Theodorus H. V πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 558 KB

Decreased expression of CD44 is an independent prognostic marker for surgically treated prostate cancer. To investigate immunohistochemically defined CD44 expression in primary and metastatic prostate cancer, 2 groups of patients undergoing radical prostatectomy for clinically localized prostate can

Emergence of metastatic hormone-refracto
Emergence of metastatic hormone-refractory disease in prostate cancer after anti-androgen therapy
✍ Edmund Chun Yu Lee; Martin P.R. Tenniswood πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 258 KB

## Abstract The anti‐androgens used in prostate cancer therapy have been designed to interfere with the normal androgen receptor (AR)‐mediated processes that ensure prostate cell survival, triggering tumor cells to undergo programmed cell death. While anti‐androgens were originally designed to trea